Kathi Niffenegger
Kathi Niffenegger occupies the position of Chief Financial Officer at Edesa Biotech, Inc. She is also Member of The American Institute of Certified Public Accountants.
Ms. Niffenegger previously occupied the position of Chief Financial Officer at Martin Aviation, Inc., Partner-Audit Division at Glenn Burdette CPAs and CFO, Secretary & Principal Accounting Officer at Stellar Biotechnologies, Inc.
She received an undergraduate degree from The California State University.
Transactions
Date
Transaction
Value
| 11/02/2022 | 8,888 | 9,954 | |
| 11/02/2022 | 8,888 | Award at $1.12 per share. | 9,954 |
| 11/06/2020 | 609 | 2,436 | |
| 11/06/2020 | 609 | 2,436 | |
| 11/06/2020 | 609 | 2,436 | |
| 01/08/2020 | 1,218 | 5,005 | |
| 01/08/2020 | 1,218 | Award at $4.11 per share. | 5,005 |
